The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: extavia     Quarter: 2016Q3

Total Records: 175     Number of Pages: 9

DRUGNAME PT EventCount
EXTAVIA Hyperhidrosis 4
EXTAVIA Hypertension 4
EXTAVIA Impaired healing 4
EXTAVIA Incorrect product storage 4
EXTAVIA Injection site discolouration 4
EXTAVIA Injection site extravasation 4
EXTAVIA Injection site macule 4
EXTAVIA Injection site nerve damage 4
EXTAVIA Injection site scar 4
EXTAVIA Injection site urticaria 4
EXTAVIA Ligament sprain 4
EXTAVIA Limb discomfort 4
EXTAVIA Liver function test increased 4
EXTAVIA Liver injury 4
EXTAVIA Loss of consciousness 4
EXTAVIA Maternal exposure during pregnancy 4
EXTAVIA Mood altered 4
EXTAVIA Muscle twitching 4
EXTAVIA Myocardial infarction 4
EXTAVIA Neck mass 4

Total Records: 175     Number of Pages: 9